Kolinsky Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.2M Buy
6,734
+382
+6% +$70.2K 0.73% 18
2024
Q3
$1.25M Sell
6,352
-79
-1% -$14.7K 0.82% 16
2024
Q2
$1.1M Buy
6,431
+136
+2% +$22.5K 0.79% 19
2024
Q1
$1.15M Buy
6,295
+529
+9% +$91.2K 0.88% 18
2023
Q4
$894K Sell
5,766
-146
-2% -$21.3K 0.79% 20
2023
Q3
$881K Buy
5,912
+6
+0.1% +$881 0.87% 16
2023
Q2
$787K Buy
5,906
+79
+1% +$11.6K 0.75% 20
2023
Q1
$929K Sell
5,827
-19
-0.3% -$2.9K 0.99% 12
2022
Q4
$945K Buy
5,846
+134
+2% +$20.5K 1.08% 10
2022
Q3
$767K Buy
5,712
+145
+3% +$20.8K 0.96% 13
2022
Q2
$853K Buy
5,567
+158
+3% +$24.1K 1.01% 12
2022
Q1
$877K Buy
5,409
+480
+10% +$69.7K 0.86% 18
2021
Q4
$667K Buy
+4,929
New +$582K 0.62% 27

Other funds holding ABBV